Invenomic Capital Management’s GP Strategies Corp. GPX Stock Holding History

Invenomic Capital Management’s Portfolio GPX Stock Details GPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-25,636	Closed	-$247K	–	186
2020 Q3	$247K	Sell	25,636 -7,996	-24%	-$70.7K	0.14%	123
2020 Q2	$289K	Hold	33,632	–	–	0.21%	118
2020 Q1	$219K	Buy	+33,632	New	+$392K	0.18%	118

Other funds holding GPX

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RCM

Rutabaga Capital Management Boston, Massachusetts $115M AUM 11.85% 1-Year Est. Return

Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return

Invenomic Capital Management's GPX Position: Q4 2020 in Review

Invenomic Capital Management sold out of GP Strategies Corp. (GPX) in Q4 2020, closing a stake of 25,636 shares — an estimated $247K sold.

Invenomic Capital Management first reported a position in GPX in Q1 2020 and held it in 3 quarters. The position peaked at $289K in Q2 2020. 76 funds tracked by Wall St. Rank hold GPX as of Q4 2020.

Invenomic Capital Management reported no remaining GP Strategies Corp. position as of Q4 2020 after selling out during the quarter.
Invenomic Capital Management sold 25,636 GP Strategies Corp. shares in Q4 2020, an estimated $247K.
Invenomic Capital Management first reported a position in GP Strategies Corp. in Q1 2020 and held it in 3 quarters.
Invenomic Capital Management's GP Strategies Corp. position peaked at $289K in Q2 2020.
76 funds tracked by Wall St. Rank held GP Strategies Corp. as of Q4 2020.

Based on Invenomic Capital Management's 13F filing for Q4 2020, filed 17 Feb 2021.